The manufacturer of Otezla has a copay card for people with private or commercial insurance. This card can decrease the copay of your medication. Sometimes, you may need prior authorization from your ...
Otezla is the first oral therapy approved for moderate to severe plaque psoriasis in this patient population. The Food and Drug Administration (FDA) has expanded the approval of Otezla ® (apremilast) ...
THOUSAND OAKS, Calif., Aug. 20, 2024 /PRNewswire/ -- Amgen (AMGN) today announced Otezla ® (apremilast) is now available in the U.S. for pediatric use. Earlier this year, the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results